Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Terminated 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Leiomyoma 12Menorrhagia 4Endometriosis 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6relugolix 5Norethindrone Acetate 5vilaprisan 4Uterine Myomectomy 3linzagolix 2Uterine Artery Embolization 2ulipristal 1Radiofrequency Ablation 1Progesterone 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Electrocoagulation 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Menorrhagia × vilaprisan × Clear all
NCT03400943 2023-05-03

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Bayer

Phase 3 Terminated
93 enrolled 19 charts

Leiomyoma, Menorrhagia

NCT03476928 2022-07-08

ASTEROID 8

Bayer

Phase 3 Terminated
153 enrolled

Leiomyoma, Menorrhagia

NCT03400956 2022-06-30

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Bayer

Phase 3 Terminated
103 enrolled 18 charts

Leiomyoma, Menorrhagia

NCT02465814 2016-11-22

ASTEROID 2

Bayer

Phase 2 Completed
120 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡